Portfolio company
G2GBIO
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops long-acting injectable medicines and drug delivery platforms for pharmaceutical companies and patients with chronic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Continuity Biosciences LLC
This company develops implantable drug delivery platforms and cell reprogramming technologies for biopharmaceutical partners to treat chronic diseases and solid tumours.
Consegna Pharma
This company develops long-acting injectable medications and drug delivery systems for healthcare providers to treat opioid overdose, addiction, and chronic pain.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
j2hbio
This company develops small molecule pharmaceuticals and provides contract manufacturing services to global pharmaceutical partners to treat rare and incurable diseases.
Optimeos Life Sciences
This company develops nanoparticle drug delivery systems and long-acting injectables for pharmaceutical partners to enable targeted intracellular delivery of genetic medicines and proteins.
Medincell
Medincell develops long-acting injectable medicines for pharmaceutical and veterinary partners to improve patient adherence across multiple therapeutic areas.
I2 Therapeutics
This company develops oral drug delivery formulations and long-acting therapies for metabolic and inflammatory diseases to improve patient adherence and treatment efficacy.
Intarcia Therapeutics
This biopharmaceutical company develops subcutaneous drug delivery implants for patients with chronic diseases such as type 2 diabetes and HIV.